- Julian Tudor Hart, retired general practitioner and honorary research fellow1
- 1University of Wales Swansea Medical School, Swansea SA3 2HH, UK
- juliantudorhart{at}yahoo.co.uk
The Cochrane review of randomised trials of treatment for “mild” hypertension, which found no benefit in drug treatment, prompts two important questions.1 Why has it taken more than 30 years to reach a conclusion that was evident from critical reading of the original trials that claimed to justify interventions in the diastolic range 90-100 mm Hg? And how can we get practice on to a more rational footing?
In 1983 I was invited to a symposium …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking